Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 21, 2022	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-22-000790.pdf 0000930413-22-000790.xls
Apr 21, 2023	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001308179-23-000729.pdf 0001308179-23-000729.xls
May 17, 2023	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-061817.pdf 0001104659-23-061817.xls
Apr 25, 2024	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001308179-24-000578.pdf 0001308179-24-000578.xls
May 22, 1996	DEFN14A	Proxy statement filed by non-management not in connection with contested solicitations	View HTML 0000940180-96-000082.pdf
Nov 21, 2001	DEFS14A	A definitive proxy statement giving notice regarding a special meeting	View HTML 0000950123-01-508707.pdf
May 26, 2020	FWP	FWP	View HTML 0001104659-20-065591.pdf
May 26, 2020	FWP	FWP	View HTML 0001104659-20-065593.pdf
Aug 07, 2020	FWP	FWP	View HTML 0001104659-20-092011.pdf 0001104659-20-092011.xls
Mar 20, 2001	POS EX	POS EX	View HTML 0000950123-01-500272.pdf

Data provided by Kaleidoscope.

Investors & Media